How do I integrate 0013 logo into my trading app?

Simply embed the API URL as an image source in your application. For example: . The API returns optimized images with proper caching headers for fast loading.

HUTCHMED (China) Limited (HKG:0013) Logo

Q: How do I get the HUTCHMED (China) Limited (HKG:0013) logo via API?

Use our Stock Logo API with the ticker symbol 0013. Make a GET request to https://api.logostream.dev/stocks/symbol/0013?key=YOUR_API_KEY to receive the logo. You can also specify format (SVG, PNG, WebP) and size parameters.

Q: What formats are available for 0013 logo?

The HUTCHMED (China) Limited (HKG:0013) logo is available in SVG, PNG, WebP, and JPG formats. SVG is recommended for scalability. Use the format parameter to specify your preferred format, e.g., ?format=svg or ?format=png.

Q: Can I use the HUTCHMED (China) Limited (HKG:0013) logo commercially?

With a logostream API subscription, you can use logos for display purposes in financial applications, trading platforms, dashboards, and portfolio trackers. The logos are provided for informational and display purposes within your application.

HUTCHMED (China) Limited (HKG:0013) symbol, logo with name and high resolution download options.

Download Logo Stock API

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Ticker

0013

Website

hutch-med.com

About HUTCHMED (China) Limited (HKG:0013)

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. The company offers Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to trea pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.

ISIN: KYG4672N1198

Ticker: 0013.HK

Ticker: 0J7G

Ticker: A2AF74

Ticker: A2PJ5B

Ticker: H7T1

Ticker: H7T2

Ticker: H7T2.DU

Ticker: H7T2.F

Ticker: H7T2.MU

Ticker: HCM

Ticker: HCM.GB

Ticker: HCM.L

Ticker: HCML

Ticker: HMDCF

Ticker: 13

Get HUTCHMED (China) Limited (HKG:0013) Logo via API

Integrate this logo into your application with a single API call

GET https://api.logostream.dev/stocks/symbol/0013?key=YOUR_API_KEY&variant=icon

View Full Documentation

Why Use Our Stock Logo API?

Fast Delivery

<100ms response time via global CDN

Enterprise-Ready

99.99% uptime SLA with GDPR compliance

Multiple Formats

SVG, PNG, WebP - scalable to any size

400k+ Logos

Stocks, ETFs, Crypto, Banks, and more

Where to Use Stock Logos

Trading Platforms

Real-time stock displays with instant logo loading

Portfolio Apps

Visualize holdings with recognizable brand logos

Financial Dashboards

Enhance market data with company branding

News & Research

Illustrate articles with accurate company logos

Frequently Asked Questions

Use our Stock Logo API with the ticker symbol 0013. Make a GET request to https://api.logostream.dev/stocks/symbol/0013?key=YOUR_API_KEY to receive the logo. You can also specify format (SVG, PNG, WebP) and size parameters.

The HUTCHMED (China) Limited (HKG:0013) logo is available in SVG, PNG, WebP, and JPG formats. SVG is recommended for scalability. Use the format parameter to specify your preferred format, e.g., ?format=svg or ?format=png.

With a logostream API subscription, you can use logos for display purposes in financial applications, trading platforms, dashboards, and portfolio trackers. The logos are provided for informational and display purposes within your application.

Simply embed the API URL as an image source in your application. For example: <img src="https://api.logostream.dev/stocks/symbol/0013?key=YOUR_API_KEY" />. The API returns optimized images with proper caching headers for fast loading.

Need Stock Logos for Your Application?

Access 380,000+ company logos via our simple REST API. Perfect for trading platforms, portfolio apps, and financial dashboards.

View Documentation Request API Key